FrancophonIA/ELRC3.0 huggingface dataset:
English: In a study comparing 8 patients with mild hepatic impairment (CPT Score A) to 8 matched controls and 8 patients with moderate hepatic impairment (CPT Score B) to 8 matched controls, the multiple dose exposure of rilpivirine was 47% higher in patients with mild hepatic impairment and 5% higher in patients with moderate hepatic impairment.
Danish: I et studie, der sammenlignede 8 patienter med let nedsat leverfunktion (CPT score A) med 8 matchede kontroller, og 8 patienter med moderat nedsat leverfunktion (CPT score B) med 8 matchede kontroller, var flerdosiseksponeringen af rilpivirin 47 % højere hos patienter med let nedsat leverfunktion, og 5 % højere hos patienter med moderat nedsat leverfunktion.
English: Overall response (HIV-1 RNA < 50 copies/mL (TLOVRa))b
Danish: Samlet respons (hiv 1-rna < 50 kopier/ml (TLOVRa))b
English: • Breakdown of muscle, muscle pain or weakness
Danish: • Muskelnedbrydning, muskelsmerter eller muskelsvaghed
English: [outer packaging only]
Danish: [Kun på den ydre emballage]
English: There is limited information regarding the use of Eviplera in patients with mild or moderate hepatic impairment (Child-Pugh-Turcotte (CPT) Score A or B).
Danish: Der er begrænset information angående brugen af Eviplera hos patienter med let nedsat eller moderat nedsat leverfunktion (Child-Pugh-Turcotte (CPT) score A eller B).
English: EU/1/11/737/002 90 (3 bottles of 30) film-coated tablets.
Danish: EU/1/11/737/001 30 filmovertrukne tabletter EU/1/11/737/002 90 (3 tabletbeholdere med 30) filmovertrukne tabletter
English: Patients had to have previously only received efavirenz/emtricitabine/tenofovir disoproxil as their first antiretroviral regimen for at least three months, and wished to switch regimens due to efavirenz intolerance.
Danish: Patienterne måtte kun have fået efavirenz/emtricitabin/ tenofovirdisoproxil som deres første antiretrovirale program, have været i behandling i mindst tre måneder og udtrykt ønske om at skifte program pga. intolerans over for efavirenz.
English: • Anaemia (low red blood cell count)
Danish: • Anæmi (lavt antal røde blodlegemer)
English: No dose adjustments are required when initiating co-administration of methadone with Eviplera.
Danish: Der kræves ingen dosisjustering, når samtidig administration af methadon og Eviplera påbegyndes.
English: Eviplera [outer packaging only]
Danish: Eviplera [kun på den ydre emballage]
English: Virologic response to tenofovir disoproxil was not reduced in patients with HIV-1 that expressed the abacavir/emtricitabine/lamivudine resistance-associated M184V substitution.
Danish: Virologisk respons over for tenofovirdisoproxil var ikke reduceret hos patienter med hiv 1, der udtrykte abacavir/emtricitabin/lamivudin resistensassocieret M184V-substitution.
English: • any other antiviral medicines that contain lamivudine or adefovir dipivoxil
Danish: • anden antiviral medicin, der indeholder lamivudin eller adefovirdipivoxil
English: Any signs of inflammation or infection.
Danish: Ethvert tegn på betændelse eller infektion.
English: After taking rilpivirine 25 mg once daily as part of an antiretroviral regimen, the total exposure of rilpivirine was lower during pregnancy (similar for the 2nd and 3rd trimester) compared with postpartum.
Danish: Efter indtagelse af rilpivirin 25 mg én gang dagligt som del af et antiretroviralt program var den samlede eksponering for rilpivirin lavere under graviditet (ens for 2. og 3. trimester) sammenlignet med postpartum.
English: • dexamethasone (a corticosteroid used to treat inflammation and suppress the immune system) when taken by mouth or injected (except as a single dose treatment)
Danish: • dexamethason (et binyrebarkhormon, der anvendes til behandling af betændelse og til undertrykkelse af immunsystemet), når det tages gennem munden eller injiceres (undtagen som en enkeltdosisbehandling).
English: The Cmax and AUC for tenofovir increased by 12% and 28% (light meal) and 32% and 38% (standard meal), respectively.
Danish: Cmax og AUC for tenofovir blev øget med hhv. 12 % og 28 % (let måltid) og 32 % og 38 % (standardmåltid).
English: Autoimmune disorders (such as Graves' disease and autoimmune hepatitis) have also been reported; however, the reported time to onset is more variable and these events can occur many months after initiation of treatment (see section 4.4).
Danish: Autoimmune lidelser (såsom Graves sygdom og autoimmun hepatitis) er også set; den rapporterede tid til udbrud er dog mere variabel og kan være mange måneder efter initiering af behandling (se pkt.
English: The safety and efficacy of Eviplera have not been established in patients with significant underlying liver disorders.
Danish: Sikkerheden og virkningen af Eviplera er ikke godtgjort hos patienter med signifikante, tilgrundliggende leversygdomme.
English: Ketoconazole:
Danish: Ketoconazol:
English: The response rate (confirmed undetectable viral load < 50 HIV-1 RNA copies/mL) at week 96 was comparable between the rilpivirine arm and the efavirenz arm.
Danish: Responsraten (bekræftet udetekterbar virusbelastning < 50 hiv 1-rna-kopier/ml) ved uge 96 var sammenlignelig i rilpivirin-armen og efavirenz-armen.
English: • Severe skin reactions including rash accompanied by fever, swelling and liver problems
Danish: • Alvorlige hudreaktioner, herunder udslæt ledsaget af feber, hævelse og leverproblemer
English: In vitro binding of tenofovir to plasma or serum protein was less than 0.7% and 7.2%, respectively, over the tenofovir concentration range 0.01 to 25 µg/mL.
Danish: Tenofovirs in vitro binding til plasma- eller serumproteiner var mindre end henholdsvis 0,7 % og 7,2 % i tenofovirkoncentrationsområdet på 0,0125 µg/ml.
English: For those patients failing therapy with Eviplera and who developed resistance to Eviplera cross-resistance to other approved NNRTIs (etravirine, efavirenz, nevirapine) was generally seen.
Danish: For de patienter, hvor behandlingen med Eviplera svigtede og som udviklede resistens over for Eviplera, blev der generelt set krydsresistens over for andre godkendte NNRTI'er (etravirin, efavirenz, nevirapin).
English: In some patients with advanced liver disease or cirrhosis, stopping treatment is not recommended as this may lead to worsening of your hepatitis, which may be lifethreatening.
Danish: Hos nogle patienter med fremskreden leversygdom eller cirrose bør behandlingen ikke ophøre, fordi det kan medføre en forværring af Deres hepatitis, hvilket kan være livstruende.
English: Emtricitabine is not significantly metabolised by liver enzymes, so the impact of liver impairment should be limited.
Danish: Emtricitabin metaboliseres ikke i en betydelig grad af leverenzymer, så betydningen af nedsat leverfunktion bør være begrænset.
English: Eviplera may interact with other medicines.
Danish: Eviplera kan påvirke anden medicin.
English: A single 245 mg dose of tenofovir disoproxil was administered to non-HIV infected subjects with varying degrees of hepatic impairment defined according to CPT classification.
Danish: En enkelt dosis af 245 mg tenofovirdisoproxil blev indgivet til ikke-hiv-inficerede personer med forskellige grader af nedsat leverfunktion defineret i henhold til CPT klassifikationen.
English: The dosing recommendation is applicable to the recommended dose of rilpivirine of 25 mg once daily.
Danish: Dosisanbefalingen gælder for den anbefalede dosis af rilpivirin på 25 mg én gang dagligt.
English: Resistance to emtricitabine or tenofovir has been seen in vitro and in some HIV-1 infected patients due to the development of the M184V or M184I substitution in RT with emtricitabine, or the K65R substitution in RT with tenofovir.
Danish: Der er observeret resistens over for emtricitabin eller tenofovir in vitro og hos nogle hiv 1-inficerede patienter på grund af udvikling af M184V- eller M184I-substitution i RT med emtricitabin eller K65Rsubstitution i RT med tenofovir.
English: Rilpivirine hydrochloride is primarily metabolised and eliminated by the liver.
Danish: Rilpivirinhydrochlorid metaboliseres og udskilles primært af leveren.
English: Discontinued study drug due to other reasons and last available HIV-1 RNA < 50 copies/mLe
Danish: Seponering af studielægemidlet af andre årsager og sidst tilgængelige hiv 1-rna < 50 kopier/mle
English: Emtricitabine/tenofovir disoproxil + rilpivirine hydrochloride has been shown to be non-inferior in achieving HIV-1 RNA < 50 copies/mL compared to emtricitabine/tenofovir disoproxil + efavirenz.
Danish: Emtricitabin/tenofovirdisoproxil+ rilpivirinhydrochlorid har vist sig at være non-inferiørt til at opnå hiv 1-rna < 50 kopier/ml, sammenlignet med emtricitabin/tenofovirdisoproxil + efavirenz.
English: The degree of renal impairment was defined according to baseline CrCl (normal renal function when CrCl > 80 mL/min; mild impairment with CrCl = 50-79 mL/min; moderate impairment with CrCl = 30-49 mL/min and severe impairment with CrCl = 10-29 mL/min).
Danish: Graden af nedsat nyrefunktion blev defineret i henhold til CrCl ved baseline (normal nyrefunktion med CrCl > 80 ml/min; let nedsat nyrefunktion med CrCl = 50-79 ml/min; moderat nedsat nyrefunktion med CrCl = 30-49 ml/min og svært nedsat nyrefunktion med CrCl = 1029 ml/min).
English: Pharmacokinetic parameters were mainly determined following administration of single doses of emtricitabine 200 mg or tenofovir disoproxil 245 mg to non-HIV infected patients with varying degrees of renal impairment.
Danish: Farmakokinetiske parametre blev hovedsageligt bestemt efter indgivelse af enkelte doser 200 mg emtricitabin eller 245 mg tenofovirdisoproxil til ikke-hiv-inficerede patienter med forskellige grader af nedsat nyrefunktion.
English: Emtricitabine and tenofovir disoproxil are excreted in human milk.
Danish: Emtricitabin og tenofovirdisoproxil udskilles i human mælk.
English: Genotoxicity and repeated dose toxicity studies of one month or less with the combination of emtricitabine and tenofovir disproxil found no exacerbation of toxicological effects compared to studies with the separate components.
Danish: I studier af en måneds varighed eller derunder af genotoksicitet og af toksicitet efter gentagne doser med en kombination af emtricitabin og tenofovirdisoproxil blev der ikke fundet nogen forværring af toksikologiske virkninger, sammenlignet med studier med de separate indholdsstoffer.
English: Co-administration of tenofovir disoproxil and didanosine at a dose of 400 mg daily has been associated with a significant decrease in CD4+ cell count, possibly due to an intracellular interaction increasing phosphorylated (i.e. active) didanosine.
Danish: Samtidig administration af tenofovirdisoproxil og didanosin i en dosis på 400 mg dagligt er blevet forbundet med en signifikant reduktion i antallet af CD4+celler, muligvis på grund af en intracellulær interaktion, der forhøjer fosforyleret (dvs. aktivt) didanosin.
English:  If you notice any symptoms of inflammation or infection, tell your doctor immediately.
Danish:  Hvis De bemærker nogle symptomer på betændelse eller infektion, skal De straks fortælle det til lægen.
English: Although rilpivirine demonstrated limited in vitro activity against HIV-2 with EC50 values ranging from 2,510 to 10,830 nM (920 to 3,970 ng/mL), treatment of HIV-2 infection with rilpivirine hydrochloride is not recommended in the absence of clinical data.
Danish: Selvom rilpivirin viste begrænset aktivitet in vitro mod hiv 2 med EC50-værdier i intervallet fra 2.510 til 10.830 nM (920 til 3.970 ng/ml), frarådes rilpivirinhydrochlorid til behandling af en hiv 2 infektion når kliniske data ikke er tilgængelige.
English: The most common emergent resistance mutations in Eviplera-treated patients were M184V/I and E138K in RT. All patients remained susceptible to tenofovir.
Danish: De almindeligste resistensmutationer hos Eviplera-behandlede patienter var M184V/I og E138K i RT. Alle patienter forblev følsomme for tenofovir.
English: The mutations associated with NRTI resistance that developed in 3 or more patients were: K65R, K70E, M184V/I and K219E during the treatment period.
Danish: Mutationerne forbundet med NRTI-resistens, der blev udviklet hos 3 eller flere patienter, var: K65R, K70E, M184V/I og K219E i løbet af behandlingsperioden.
English: The combination of emtricitabine, rilpivirine and tenofovir disoproxil has been studied as the component products in treatment-naïve patients (Phase III studies C209 and C215).
Danish: Kombinationen af emtricitabin, rilpivirin og tenofovirdisoproxil er blevet undersøgt som komponentpræparater hos behandlingsnaive patienter (fase III-studier C209 og C215).
English: Studies in animals have shown limited placenta passage of rilpivirine.
Danish: Dyrestudier har vist begrænset passage gennem placenta af rilpivirin.
English: Animal studies do not indicate harmful effects of emtricitabine, rilpivirine hydrochloride or tenofovir disoproxil on fertility.
Danish: Dyreforsøg indikerer ingen skadelige virkninger af emtricitabin rilpivirinhydrochlorid eller tenofovirdisoproxil på fertiliteten.
English: Patients with pre-existing liver dysfunction, including chronic active hepatitis, have an increased frequency of liver function abnormalities during combination antiretroviral therapy (CART) and should be monitored according to standard practice.
Danish: Hos patienter med tidligere tilfælde af leverdysfunktion, herunder kronisk aktiv hepatitis, er der en forhøjet forekomst af unormal leverfunktion under antiretroviral kombinationsbehandling (CART), og disse patienter bør monitoreres i henhold til standardprocedurer.
English: CCR5 antagonists Maraviroc/Emtricitabine
Danish: CCR5-antagonister Maraviroc/Emtricitabin
English: The effect of rilpivirine hydrochloride at the recommended dose of 25 mg once daily on the QTcF interval was evaluated in a randomised, placebo and active (moxifloxacin 400 mg once daily) controlled crossover study in 60 healthy adults, with 13 measurements over 24 hours at steady-state.
Danish: Virkningen af rilpivirinhydrochlorid ved den anbefalede dosis på 25 mg én gang dagligt på QTcFintervallet blev evalueret i et randomiseret, placebo- og aktivt kontrolleret (moxifloxacin 400 mg én gang dagligt) overkrydsningsstudie med 60 raske voksne, med 13 målinger i løbet af 24 timer ved steady-state.
English: In another study, the Y188L substitution resulted in a reduced susceptibility to rilpivirine of 9-fold for clinical isolates and 6-fold for site-directed mutants.
Danish: I et andet studie resulterede Y188Lsubstitution i 9 gange nedsat følsomhed for rilpivirin hos kliniske isolater og i 6 gange nedsat følsomhed hos mutanter, der er rettet mod et bestemt mål.
English: Lower exposures of rilpivirine were observed during pregnancy; therefore viral load should be monitored closely.
Danish: Der er observeret lavere eksponeringer for rilpivirin under graviditet, hvorfor virusbelastningen bør monitoreres tæt.
English: • Increases in creatinine in your blood
Danish: • Øget kreatinin i blodet
English: If serum phosphate is < 1.5 mg/dL (0.48 mmol/L) or CrCl is decreased to < 50 mL/min in any patient receiving Eviplera, renal function should be re-evaluated within one week, including measurements of blood glucose, blood potassium and urine glucose concentrations (see section 4.8, proximal tubulopathy).
Danish: Hvis serumphosphat er < 1,5 mg/dl (0,48 mmol/l) eller CrCl er faldende til < 50 ml/min hos patienter, der får Eviplera, skal vurderingen af nyrefunktionen gentages inden for en uge, herunder måling af glucose- og kaliumkoncentration i blodet samt uringlucose (se pkt.
English: Rilpivirine exhibited activity against laboratory strains of wild-type HIV-1 in an acutely infected T-cell line with a median EC50 value for HIV-1/IIIB of 0.73 nM (0.27 ng/mL).
Danish: Rilpivirin udviste aktivitet mod laboratoriestammer af vildtype hiv 1 i en akut inficeret T-cellelinje med en median EC50-værdi for hiv 1/IIIB på 0,73 nM (0,27 ng/ml).
English: The Cmax and AUC of rilpivirine increased by 34% and 9% (light meal) and 26% and 16% (standard meal), respectively.
Danish: Cmax og AUC for rilpivirin blev øget med hhv. 34 % og 9 % (let måltid) og 26 % og 16 % (standardmåltid).
English: H2-antagonists should not be taken twice a day.
Danish: H2-antagonister bør ikke tages to gange dagligt.
English: High density polyethylene (HDPE) bottle with a polypropylene child-resistant closure containing 30 film-coated tablets and a silica gel desiccant.
Danish: Højdensitets-polyethylen (HDPE)-beholder med børnesikret lukke af polypropylen indeholdende 30 filmovertrukne tabletter sammen med silicagel-tørremiddel.
English: Patients with HIV-1 expressing three or more TAMs that included either the M41L or L210W RT substitution showed reduced response to tenofovir disoproxil.
Danish: Patienter, hvis hiv 1 udtrykte 3 eller flere TAMs, som omfattede enten M41L- eller L210W-RTsubstitution, udviste reduceret respons over for tenofovirdisoproxil.
English: In study C215 (n = 678), the BR consisted of 2 investigator selected N(t)RTIs: emtricitabine/tenofovir disoproxil (60%, n = 406) or lamivudine/zidovudine (30%, n = 204) or abacavir plus lamivudine (10%, n = 68).
Danish: I studie C215 (n = 678) bestod BR af 2 N(t)RTI'er udvalgt af investigatoren: Emtricitabin/tenofovirdisoproxil (60 %, n = 406) eller lamivudin/zidovudin (30 %, n = 204) eller abacavir plus lamivudin (10 %, n = 68).
English: If you vomit more than 4 hours after taking Eviplera you do not need to take another tablet until your next regularly scheduled tablet.
Danish: Hvis De kaster op mere end 4 timer efter, De har taget Eviplera, behøver De ikke tage en ny tablet, før Deres næste regelmæssigt skemalagte tablet.
English: Your doctor may need to give you an additional dose of rilpivirine to treat your HIV infection (see section 3, How to take Eviplera).
Danish: Dem en yderligere dosis rilpivirin til behandling af Deres hiv-infektion (se punkt 3, Sådan skal De tage Eviplera).
English: The frequency category of uncommon was estimated from a statistical calculation based on the total number of patients exposed to emtricitabine in these clinical studies (n = 1,563).
Danish: Hyppighedskategorien Ikke almindelig blev estimeret ud fra en statistisk beregning baseret på det totale antal patienter eksponeret for emtricitabin i disse kliniske studier (n = 1.563)
English: Due to similarities with emtricitabine, Eviplera should not be administered concomitantly with other cytidine analogues, such as lamivudine (see section 4.4).
Danish: På grund af lighederne med emtricitabin bør Eviplera ikke administreres samtidigt med andre cytidinanaloger, såsom lamivudin (se pkt.
English: • Signs or symptoms of inflammation or infection
Danish: • Tegn eller symptomer på betændelse eller infektion
English: The mean baseline CD4 cell count was 584 x 106 cells/L (range 42-1,484).
Danish: Det gennemsnitlige CD4-celletal ved baseline var 584 x 106 celler/l (interval 42-1.484).
English: One patient (2%) did not have data available in the week 48 window; study drug was discontinued due to a protocol violation (i.e. reason other than AE or death) and the last available HIV-1 RNA was < 50 copies/mL.
Danish: Der var ingen tilgængelige data for en patient (2 %) i uge 48-perioden; studielægemidlet blev seponeret pga. protokolovertrædelse (dvs. en anden årsag end bivirkninger eller død); i den sidst tilgængelige analyse var hiv 1-rna < 50 kopier/ml.
English: Renal elimination of rilpivirine is negligible.
Danish: Nyreudskillelsen af rilpivirin er ubetydelig.
English: • Decreases in phosphate levels in the blood
Danish: • Fald i phosphatniveauet i blodet
English: Posaconazole2 Voriconazole2
Danish: Posaconazol2 Voriconazol2
English: Eviplera 200 mg/25 mg/245 mg film-coated tablets
Danish: Eviplera 200 mg/25 mg/245 mg filmovertrukne tabletter
English: It was also identified as an adverse reaction for emtricitabine through post-marketing surveillance but was not observed in randomised controlled clinical studies in adults or paediatric HIV clinical studies of emtricitabine.
Danish: Den blev også identificeret som en bivirkning for emtricitabin under sikkerhedsovervågningen efter markedsføring, men den blev ikke observeret i randomiserede, kontrollerede kliniske studier af emtricitabin til voksne eller pædiatriske hiv-patienter.
English: After oral administration of the single components emtricitabine and tenofovir disoproxil, emtricitabine and tenofovir are widely distributed throughout the body.
Danish: Efter oral indgivelse af de enkelte komponenter emtricitabin og tenofovirdisoproxil fordeles emtricitabin og tenofovir i stort omfang i hele legemet.
English: In virologically suppressed HIV-1 infected patients In study GS-US-264-0106, 4 of the 469 patients who switched from a ritonavir-PI-based regimen to Eviplera had HIV-1 with reduced susceptibility to at least one component of Eviplera through week 48.
Danish: Hos virologisk supprimerede hiv 1-inficerede patienter I studie GS-US-264-0106 havde 4 af de 469 patienter, som skiftede fra et ritonavir-PI-baseret program til Eviplera, hiv 1 med nedsat følsomhed for mindst et af stofferne i Eviplera til og med uge 48.
English: Resistance to rilpivirine2 Cross-resistance3 to etravirine efavirenz nevirapine
Danish: Resistens over for rilpivirin1 Krydsresistens2 over for etravirin efavirenz nevirapin
English: 4 Anaemia was common and skin discolouration (increased pigmentation) was very common when emtricitabine was administered to paediatric patients (see section 4.8, Paediatric population).
Danish: 4 Anæmi var almindelig og misfarvning af huden (øget pigmentering) meget almindelig, når emtricitabin blev indgivet til pædiatriske patienter (se pkt.
English: At week 48, 89% (283/317) of patients randomised to switch to Eviplera at baseline (Eviplera) had HIV-1 RNA < 50 copies/mL, 3% (8/317) were considered virologic failures (HIV RNA ≥ 50 copies/mL), and 8% (26/317) did not have data available in the week 48 window.
Danish: Ved uge 48 havde 89 % (283/317) af patienterne, som blev randomiseret til skift til Eviplera ved baseline (Eviplera), hiv 1-rna < 50 kopier/ml, 3 % (8/317) blev anset som havende virologiske svigt (hiv-rna ≥ 50 kopier/ml), og 8 % (26/317) havde ikke tilgængelige data i uge 48-perioden.
English: HIV patients with liver disease (including chronic hepatitis B or C), who are treated with antiretrovirals, have a higher risk of severe and potentially fatal liver complications.
Danish: Hiv-patienter med leversygdom (herunder kronisk hepatitis B eller C), som behandles med antiretrovirale lægemidler, har en højere risiko for alvorlige og potentielt dødelige leverkomplikationer.
English: Purplish-pink, capsule-shaped, film-coated tablet of dimensions 19 mm x 8.5 mm, debossed on one side with “GSI” and plain on the other side.
Danish: Lilla-lyserøde kapselformede, filmovertrukne tabletter, der måler 19 mm x 8,5 mm, og som er præget med „GSI” på den ene side og glatte på den anden side.
English: It is important not to miss a dose of Eviplera.
Danish: Det er vigtigt, at De husker at tage hver dosis af Eviplera.
English: Patients had to be stably suppressed for at least 8 weeks prior to study entry, have no current or past history of resistance to any of the three components of Eviplera, and have HIV-1 RNA < 50 copies/mL at screening.
Danish: Patienterne skulle være stabilt supprimerede i mindst 8 uger inden deltagelse i studiet, ikke have nuværende eller tidligere resistens over for nogen af de tre stoffer i Eviplera i anamnesen og have hiv 1-rna < 50 kopier/ml ved screening.
English: Eviplera is not recommended for patients with moderate or severe renal impairment (CrCl < 50 mL/min).
Danish: Eviplera frarådes til patienter med moderat eller svært nedsat nyrefunktion (CrCl < 50 ml/min).
English: Lower exposures of rilpivirine (one of the components of Eviplera) were observed during pregnancy; therefore viral load should be monitored closely.
Danish: Der er observeret lavere eksponeringer for rilpivirin (et af indholdsstofferne i Eviplera) under graviditet, hvorfor virusbelastningen bør monitoreres tæt.
English: These medicines can increase the amount of rilpivirine (a component of Eviplera) in your blood.
Danish: Disse former for medicin kan øge mængden af rilpivirin (en komponent i Eviplera) i Deres blod.
English: H2-RECEPTOR ANTAGONISTS Famotidine/Emtricitabine
Danish: H2-RECEPTORANTAGONISTER Famotidin/Emtricitabin